Literature DB >> 34596698

Longer treatment time and lower radiation doses-an alternative for Graves' ophthalmopathy treatment.

Cem Onal1,2, Ozan Cem Guler3.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34596698     DOI： 10.1007/s00066-021-01852-8

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   4.033


× No keyword cloud information.
  6 in total

1.  Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study.

Authors:  M P Mourits; M L van Kempen-Harteveld; M B García; H P Koppeschaar; L Tick; C B Terwee
Journal:  Lancet       Date:  2000-04-29       Impact factor: 79.321

2.  Low- versus high-dose radiotherapy for Graves' ophthalmopathy: a randomized, single blind trial.

Authors:  G J Kahaly; H P Rösler; S Pitz; G Hommel
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

Review 3.  Graves' ophthalmopathy treated with protracted hypofractionated low-dose adaptive radiotherapy: case report and review of the literature.

Authors:  Ozan Cem Guler; Cem Onal; Gungor Arslan
Journal:  Wien Klin Wochenschr       Date:  2015-10-14       Impact factor: 1.704

4.  Protracted hypofractionated radiotherapy for Graves' ophthalmopathy: a pilot study of clinical and radiologic response.

Authors:  Cejana Casimiro de Deus Cardoso; Adelmo José Giordani; Angela Maria Borri Wolosker; Luis Souhami; Paulo Gois Manso; Rodrigo Souza Dias; Helena Regina Comodo Segreto; Roberto Araujo Segreto
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-05-06       Impact factor: 7.038

5.  Retrobulbar irradiation for thyroid-associated orbitopathy: double-blind comparison between 2.4 and 16 Gy.

Authors:  Jürgen Gerling; Guntram Kommerell; Karl Henne; Jörg Laubenberger; Jürgen Schulte-Mönting; Peter Fells
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-01-01       Impact factor: 7.038

6.  Low- vs. high-dose radiotherapy in Graves' ophthalmopathy: a retrospective comparison of long-term results.

Authors:  Thomas Weissmann; Sebastian Lettmaier; Anna-Jasmina Donaubauer; Christoph Bert; Manfred Schmidt; Friedrich Kruse; Oliver Ott; Markus Hecht; Rainer Fietkau; Benjamin Frey; Florian Putz
Journal:  Strahlenther Onkol       Date:  2021-04-16       Impact factor: 4.033
  6 in total
  1 in total

1.  Reply to: Longer treatment time and lower radiation doses-an alternative for Graves' ophthalmopathy treatment.

Authors:  Thomas Weissmann; Florian Putz; Benjamin Frey
Journal:  Strahlenther Onkol       Date:  2022-04-25       Impact factor: 4.033
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.